Rainer Prof Dr Dietz

Rainer Prof Dr Dietz's AcademicInfluence.com Rankings

Philosophy

#7287

World Rank

#10479

Historical Rank

Logic

#4343

World Rank

#5625

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Rainer Prof Dr Dietz Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Rainer Prof Dr Dietz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. (2003) (1421)
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. (2000) (1183)
Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy (2004) (790)
Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. (2005) (738)
The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. (2003) (724)
[Guidelines on the management of stable angina pectoris: executive summary]. (2006) (705)
Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients with Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) (2000) (595)
Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. (1999) (595)
Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. (1998) (567)
Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey (2002) (564)
Delayed Enhancement and T2-Weighted Cardiovascular Magnetic Resonance Imaging Differentiate Acute From Chronic Myocardial Infarction (2004) (558)
The application of methods of non-linear dynamics for the improved and predictive recognition of patients threatened by sudden cardiac death. (1996) (459)
The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. (2008) (455)
Release of Endogenous Catecholamines in the Ischemic Myocardium of the Rat: Part A Locally Mediated Release (1984) (399)
Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy (1998) (367)
Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction: Results of the CHARM Low–Left Ventricular Ejection Fraction Trials (2004) (349)
Optimization and validation of a fully‐integrated pulse sequence for modified look‐locker inversion‐recovery (MOLLI) T1 mapping of the heart (2007) (342)
AT1 Receptor Agonistic Antibodies From Preeclamptic Patients Stimulate NADPH Oxidase (2003) (337)
Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. (2009) (328)
Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. (1997) (296)
Mutations in the Human Muscle LIM Protein Gene in Families With Hypertrophic Cardiomyopathy (2003) (251)
Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. (1999) (248)
Hemodynamic and Neurohumoral Effects of Selective Endothelin A (ETA) Receptor Blockade in Chronic Heart Failure: The Heart Failure ETA Receptor Blockade Trial (HEAT) (2002) (236)
Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. (2001) (208)
High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha. (1997) (206)
Reactive oxygen species induce apoptosis of vascular smooth muscle cell (1997) (199)
Requirement of Nuclear Factor-&kgr;B in Angiotensin II– and Isoproterenol-Induced Cardiac Hypertrophy In Vivo (2005) (191)
Phosphorylation by protein kinase CK2: a signaling switch for the caspase-inhibiting protein ARC. (2002) (186)
Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease (2008) (185)
Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. (2009) (174)
The Euro Heart Failure Survey of The EUROHEART Survey Programme: A survey on the quality of care among patients with heart failure in Europe (2000) (173)
Lowering of hypertension by central saralasin in the absence of plasma renin (1977) (173)
A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure. (2006) (172)
Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein. (1997) (171)
Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial (2011) (166)
Release of Endogenous Catecholamines in the Ischemic Myocardium of the Rat: Part B Effect of Sympathetic Nerve Stimulation (1984) (158)
Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy. (2008) (157)
Baroreflex sensitivity and cardiovascular mortality in patients with mild to moderate heart failure. (1995) (153)
Evidence for the presence of enkephalins in the heart. (1983) (153)
T1 mapping in patients with acute myocardial infarction. (2003) (151)
Central blood pressure effects of substance P and angiotensin II: role of the sympathetic nervous system and vasopressin. (1981) (151)
Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. (2009) (147)
Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging-a pilot study. (2001) (147)
High human renin hypertension in transgenic rats. (1997) (146)
Practical recommendations for the use of ACE inhibitors, beta‐blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice (2005) (144)
Time Course of Restenosis During the First Year After Emergency Coronary Stenting (1993) (140)
&bgr;-Catenin Downregulation Is Required for Adaptive Cardiac Remodeling (2007) (138)
Vascular Endothelial Cell–Specific NF-&kgr;B Suppression Attenuates Hypertension-Induced Renal Damage (2007) (138)
Left atrial systolic and diastolic dysfunction in heart failure with normal left ventricular ejection fraction. (2011) (129)
Long-term follow-up of patients with acute myocarditis by magnetic resonance imaging (2003) (126)
β-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation (2008) (126)
Contrast-enhanced cardiovascular magnetic resonance imaging of right ventricular infarction. (2006) (126)
Public awareness of heart failure in Europe: first results from SHAPE. (2005) (123)
Effects of central and peripheral angiotensin blockade in hypertensive rats. (1978) (122)
A gain-of-function TBX20 mutation causes congenital atrial septal defects, patent foramen ovale and cardiac valve defects (2009) (116)
Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B. (2006) (115)
Differential regulation of cardiac ANP and BNP mRNA in different stages of experimental heart failure. (2000) (114)
Apoptosis Repressor With Caspase Recruitment Domain Is Required for Cardioprotection in Response to Biomechanical and Ischemic Stress (2006) (105)
Cardiovascular magnetic resonance of acute myocardial infarction at a very early stage. (2003) (105)
Determination of renal arterial stenosis severity: comparison of pressure gradient and vessel diameter. (2001) (104)
Prevalence of aspirin resistance in patients with type 2 diabetes (2005) (102)
Elective stenting of carotid artery stenosis in patients with severe coronary artery disease. (1998) (100)
Quantification of valvular aortic stenosis by magnetic resonance imaging. (2002) (99)
Aspirin inhibits NF‐κB and protects from angiotensin II‐induced organ damage (2001) (96)
Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease (2008) (95)
Platelet Degranulation Is Associated With Progression of Intima-Media Thickness of the Common Carotid Artery in Patients With Diabetes Mellitus Type 2 (2005) (94)
Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance (2005) (93)
Requirement for protein kinase C in reactive oxygen species-induced apoptosis of vascular smooth muscle cells. (1999) (93)
Blood Oxygen Level–Dependent Magnetic Resonance Imaging in Patients with Stress-Induced Angina (2003) (93)
Percutaneous treatment of pseudoaneurysms and arteriovenous fistulas after invasive vascular procedures (1999) (91)
Angiotensin-converting enzyme and angiotensinogen gene polymorphisms and heart rate variability in twins. (1998) (90)
Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathy (2001) (89)
Potential Relevance of α1-Adrenergic Receptor Autoantibodies in Refractory Hypertension (2008) (88)
Mutations in GATA4, NKX2.5, CRELD1, and BMP4 are infrequently found in patients with congenital cardiac septal defects (2008) (88)
Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy (2002) (87)
Emergency coronary stenting for dissection during percutaneous transluminal coronary angioplasty: angiographic follow-up after stenting and after repeat angioplasty of the stented segment. (1994) (86)
The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization. (2000) (86)
Dysfunction of dysferlin-deficient hearts (2007) (86)
An open-source software tool for the generation of relaxation time maps in magnetic resonance imaging (2010) (86)
Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes. (2009) (84)
Right ventricular myocardial systolic and diastolic dysfunction in heart failure with normal left ventricular ejection fraction. (2011) (84)
Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats (2001) (81)
Prediction of life-threatening arrhythmic events in patients with chronic myocardial infarction by contrast-enhanced CMR. (2011) (81)
E2F-1 overexpression in cardiomyocytes induces downregulation of p21CIP1 and p27KIP1 and release of active cyclin-dependent kinases in the presence of insulin-like growth factor I. (1999) (81)
ACE inhibition improves vagal reactivity in patients with heart failure. (1990) (79)
NF-kappaB activation is required for adaptive cardiac hypertrophy. (2009) (76)
Antihypertensive Effect of the GABA Receptor Agonist Muscimol in Spontaneously Hypertensive Rats: Role of the Sympathoadrenal Axis (1984) (76)
A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy. (2008) (76)
Investigation of a family with autosomal dominant dilated cardiomyopathy defines a novel locus on chromosome 2q14-q22. (1999) (74)
Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy (2008) (73)
Angiotensin-converting enzyme and heart chymase gene polymorphisms in hypertrophic cardiomyopathy. (1996) (72)
Stent implantation in patients with superior vena cava syndrome. (1997) (71)
Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg-Strauss syndrome. (2008) (70)
Regulation of Vascular Smooth Muscle Cell Proliferation: Role of NF-&kgr;B Revisited (2005) (70)
Angiotensin II-induced sudden arrhythmic death and electrical remodeling. (2007) (69)
Changes in vascular smooth muscle sensitivity to vasoconstrictor agents induced by corticosteroids, adrenalectomy and differing salt intake in rats. (1976) (69)
Increased expression of renal neutral endopeptidase in severe heart failure. (2002) (69)
Relation between myocardial edema and myocardial mass during the acute and convalescent phase of myocarditis – a CMR study (2008) (69)
A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy. (2001) (68)
Hydroxymethylglutaryl Coenzyme A Reductase Inhibition Reduces Chlamydia pneumoniae‐Induced Cell Interaction and Activation (2003) (68)
Effect of NF- κ B Inhibition on TNF- α -induced Apoptosis and Downstream Pathways in Cardiomyocytes (2001) (68)
Contrast–dose relation in first‐pass myocardial MR perfusion imaging (2007) (67)
Vectorcardiographic monitoring to assess early vessel patency after reperfusion therapy for acute myocardial infarction. (1995) (67)
Critical Role for FoxO3a-Dependent Regulation of p21CIP1/WAF1 in Response to Statin Signaling in Cardiac Myocytes (2007) (67)
Prevalence of cardiac beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy (2005) (66)
Left ventricular outflow tract planimetry by cardiovascular magnetic resonance differentiates obstructive from non-obstructive hypertrophic cardiomyopathy. (2006) (65)
Statins inhibit reoxygenation-induced cardiomyocyte apoptosis: role for glycogen synthase kinase 3β and transcription factor β-catenin (2004) (65)
Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach (2008) (64)
Mutations in the cardiac transcription factor GATA4 in patients with lone atrial fibrillation. (2010) (64)
Improvement of fractional flow reserve and collateral flow by treatment with external counterpulsation (Art.Net.‐2 Trial) (2009) (63)
The heart in Anderson Fabry disease (2002) (63)
Identification of a cis-acting regulatory element conferring inducibility of the atrial natriuretic factor gene in acute pressure overload. (1997) (61)
Regenerative capacity of the myocardium: implications for treatment of heart failure (2004) (61)
Protein kinase CK2 links extracellular growth factor signaling with the control of p27Kip1 stability in the heart (2008) (60)
Plasma atrial natriuretic peptide values in cardiac disease. (1986) (60)
Enhanced sympathetic activity caused by salt loading in spontaneously hypertensive rats. (1980) (60)
Blood Oxygen Level–Dependent MRI of Tissue Oxygenation: Relation to Endothelium-Dependent and Endothelium-Independent Blood Flow Changes (2005) (58)
p21CIP1 Controls Proliferating Cell Nuclear Antigen Level in Adult Cardiomyocytes (2003) (57)
Stabilization of hypoxia inducible factor rather than modulation of collagen metabolism improves cardiac function after acute myocardial infarction in rats (2006) (56)
ARC is a critical cardiomyocyte survival switch in doxorubicin cardiotoxicity (2009) (55)
A novel isoform of the smooth muscle cell differentiation marker smoothelin (1999) (55)
Rationale, design, and organization of the metoprolol CR/XL randomized intervention trial in heart failure (MERIT-HF) (1997) (54)
Reoxygenation after severe hypoxia induces cardiomyocyte hypertrophy in vitro: activation of CREB downstream of GSK3β (2004) (54)
Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial (2008) (54)
The pharmacological relevance of vital staining with neutral red (1979) (54)
A mammalian myocardial cell-free system to study cell cycle reentry in terminally differentiated cardiomyocytes. (1999) (53)
Increasing awareness and improving the management of heart failure in Europe: the IMPROVEMENT of HF initiative (1999) (53)
Recovery from peripartum cardiomyopathy after treatment with bromocriptine (2008) (53)
Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition. (2001) (52)
Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage. (2001) (52)
Safety of implantable coronary stents during 1H-magnetic resonance imaging at 1.0 and 1.5 T. (1999) (52)
Heart rate variability before the onset of ventricular tachycardia: differences between slow and fast arrhythmias. (2002) (52)
Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice. (2001) (50)
Inhibition of Hypoxia-Induced Apoptosis by Modulation of Retinoblastoma Protein–Dependent Signaling in Cardiomyocytes (2002) (50)
The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich's ataxia (2001) (50)
Effects of an orally active converting-enzyme inhibitor, SQ 14225, on pressor responses to angiotensin administered into the brain ventricles of spontaneously hypertensive rats. (1979) (49)
Ostial renal artery stent placement for atherosclerotic renal artery stenosis in patients with coronary artery disease. (1998) (49)
Cardiac energetics correlates to myocardial hypertrophy in Friedreich's ataxia (2003) (48)
Contribution of the Sympathetic Nervous System to the Hypertensive Effect of a High Sodium Diet in Stroke‐Prone Spontaneously Hypertensive Rats (1982) (48)
The mode of onset of ventricular tachycardia. A patient-specific phenomenon. (1997) (48)
A new model of congestive heart failure in the mouse due to chronic volume overload (2001) (48)
Rat corin gene: molecular cloning and reduced expression in experimental heart failure. (2004) (46)
Genetic and phenotypic analysis of dilated cardiomyopathy with conduction system disease: Demand for strategies in the management of presymptomatic lamin A/C mutant carriers (2006) (46)
Urokinase-dependent Human Vascular Smooth Muscle Cell Adhesion Requires Selective Vitronectin Phosphorylation by Ectoprotein Kinase CK2* (2002) (46)
Urokinase Induces Activation and Formation of Stat4 and Stat1-Stat2 Complexes in Human Vascular Smooth Muscle Cells* (1999) (45)
Optimization of cardiac resynchronization guided by Doppler echocardiography: haemodynamic improvement and intraindividual variability with different pacing configurations and atrioventricular delays. (2006) (45)
Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension1 (2008) (45)
Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes. (2008) (44)
Long-term follow-up of patients paragraph sign with acute myocarditis by magnetic paragraph sign resonance imaging. (2003) (44)
A network against failing hearts--introducing the German "Competence Network Heart Failure". (2010) (43)
The severity of chronic heart failure due to coronary artery disease predicts the endocrine effects of short-term growth hormone administration. (2000) (43)
The somatotrophic system in patients with dilated cardiomyopathy: Relation of insulin‐like growth factor‐1 and its alterations during growth hormone therapy to cardiac function (2000) (42)
The E-selectin SER128ARG gene polymorphism and restenosis after successful coronary angioplasty. (2002) (42)
Single‐ or dual‐bolus approach for the assessment of myocardial perfusion reserve in quantitative MR perfusion imaging (2008) (42)
Rosuvastatin regulates vascular smooth muscle cell phenotypic modulation in vascular remodeling: role for the urokinase receptor. (2007) (41)
Influence of captopril on the arterial baroreceptor reflex in patients with heart failure. (1988) (41)
Synergistic effects of AT(1) and ET(A) receptor blockade in a transgenic, angiotensin II-dependent, rat model. (2000) (41)
Role of right and left atrial dimensions for release of atrial natriuretic peptide in left-sided valvular heart disease and idiopathic dilated cardiomyopathy. (1988) (39)
Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. (2005) (39)
Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach (2007) (38)
Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis. (1994) (38)
Effect of binge drinking on the heart as assessed by cardiac magnetic resonance imaging. (2010) (37)
Effect of NF-kappa B Inhibition on TNF-alpha-induced apoptosis and downstream pathways in cardiomyocytes. (2001) (37)
Growth Hormone Treatment in Dilated Cardiomyopathy (2001) (37)
Influence of sustained mechanical stress on Egr-1 mRNA expression in cultured human endothelial cells (2000) (37)
Improvement of vagal tone by ACE inhibition: a mechanism of cardioprotection in patients with mild-to-moderate heart failure. (1996) (37)
Safety Aspects of Deep Sedation during Catheter Ablation of Atrial Fibrillation (2012) (36)
Intravenous thrombolytic therapy with a combination of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator in acute myocardial infarction. (1990) (36)
Paradoxical Role of Neuronal Uptake for the Locally Mediated Release of Endogenous Noradrenaline in the Ischemic Myocardium (1985) (36)
Feasibility of Cardiovascular Magnetic Resonance to Assess the Orifice Area of Aortic Bioprostheses (2009) (36)
Krueppel-like factor 15 regulates Wnt/β-catenin transcription and controls cardiac progenitor cell fate in the postnatal heart (2012) (34)
Statins inhibit reoxygenation-induced cardiomyocyte apoptosis: role for glycogen synthase kinase 3beta and transcription factor beta-catenin. (2004) (34)
Monocyte-Expressed Urokinase Regulates Human Vascular Smooth Muscle Cell Migration in a Coculture Model (2002) (34)
Gender‐specific differences in left ventricular remodelling and fibrosis in hypertrophic cardiomyopathy: Insights from cardiovascular magnetic resonance (2008) (33)
Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction. (1997) (33)
Subacute coronary stent thrombosis in cancer patients. (2008) (33)
[Drug-eluting coronary stents and drug eluting balloon catheters: summary of the position papers of the DGK]. (2008) (33)
Electrical Remodeling and Cardiac Dimensions in Patients Treated by Cardiac Resynchronization and Heart Failure Controls (2007) (33)
Single Lipoprotein Apheresis Session Improves Cardiac Microvascular Function in Patients With Elevated Lipoprotein(a): Detection by Stress/Rest Perfusion Magnetic Resonance Imaging (2009) (33)
Development of a New Strain of Spontaneously Hypertensive Rats Homozygous for Hypothalamic Diabetes Insipidus (1983) (33)
Effects of cocaine and desipramine on the neurally evoked overflow of endogenous noradrenaline from the rat heart (1983) (32)
Angiotensin-converting enzyme inhibitors and renal function in heart failure. (1992) (31)
Decision‐analytic evaluation of the clinical effectiveness and cost‐effectiveness of management programmes in chronic heart failure (2008) (31)
Percutaneous Transluminal Septal Artery Ablation Using Polyvinyl Alcohol Foam Particles for Septal Hypertrophy in Patients with Hypertrophic Obstructive Cardiomyopathy: Acute and 3-Year Outcomes (2004) (31)
Intracellular superoxide induces apoptosis in VSMCs: Role of mitochondrial membrane potential, cytochrome c and caspases (2002) (31)
Reversal of corticosterone-induced supersensitivity of vascular smooth muscle to noradrenaline by arachidonic acid and prostacyclin. (1980) (31)
Magnetic resonance to assess the aortic valve area in aortic stenosis. (2004) (30)
Familial and genetic influences on heart rate variability. (1996) (30)
Relation between arteriosclerosis in the coronary and renal arteries. (1997) (29)
Angiotensin II type 1 receptor expression in human coronary arteries with variable degrees of atherosclerosis (2002) (29)
Regulation of E2F1-Dependent Gene Transcription and Apoptosis by the ETS-Related Transcription Factor GABPγ1 (2002) (28)
Fabry Disease: Focus on Cardiac Manifestations and Molecular Mechanisms (2002) (28)
A pilot study of chronic, low‐dose epoetin‐β following percutaneous coronary intervention suggests safety, feasibility, and efficacy in patients with symptomatic ischaemic heart failure (2011) (28)
Elective percutaneous coronary intervention immediately impairs resting microvascular perfusion assessed by cardiac magnetic resonance imaging. (2006) (26)
Baseline Doppler parameters are useful predictors of chronic left ventricular reduction in size by cardiac resynchronization therapy. (2007) (26)
Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography. (2008) (26)
Mechanisms Controlling Release of Atrial Natriuretic Peptide (1987) (25)
Modulation of sympathetic vascular tone by prostaglandins in corticosterone-induced hypertension in rats. (1979) (25)
Role of nitric oxide in the vasodilator effect of recombinant human growth hormone in patients with dilated cardiomyopathy. (2000) (24)
The impact of anaemia and kidney function in congestive heart failure and preserved systolic function. (2005) (24)
Partial replacement of sodium by potassium in the diet restores impaired noradrenaline inactivation and lowers blood pressure in stroke-prone spontaneously hypertensive rats. (1981) (24)
Variations in DSG2: V56M, V158G and V920G are not pathogenic for arrhythmogenic right ventricular dysplasia/cardiomyopathy (2008) (24)
Effect of noradrenaline and isoproterenol on lipopolysaccharide-induced tumor necrosis factor-alpha production in whole blood from patients with chronic heart failure and the role of beta-adrenergic receptors. (2005) (24)
Visualization of cardiac involvement in patients with systemic sarcoidosis applying contrast-enhanced magnetic resonance imaging (2000) (24)
Improvement of cardiac function by angiotensin converting enzyme inhibition. Sites of action. (1993) (24)
Vitronectin Concentrations Predict Risk in Patients Undergoing Coronary Stenting (2009) (23)
The diagnostic impact of 2D- versus 3D- left ventricular volumetry by MRI in patients with suspected heart failure (2000) (23)
Euro heart failure survey (2005) (23)
Intravenous carbochromen: a potent and effective drug for estimation of coronary dilatory capacity. (1990) (23)
Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt. (1996) (22)
Regulation of caspase 3 and Fas in pressure overload‐induced left ventricular dysfunction (2004) (22)
IS ATRIAL DISTENSION THE PHYSIOLOGICAL STIMULUS FOR RELEASE OF ATRIAL NATRIURETIC PEPTIDE? (1987) (22)
Optimal heart failure therapy and successful cardioversion in heart failure patients with atrial fibrillation. (2008) (22)
Is target dose the treatment target? Uptitrating beta-blockers for heart failure in the elderly. (2012) (22)
Survival and Appropriate Device Interventions in Recipients of Cardioverter Defibrillators Implanted for the Primary Versus Secondary Prevention of Sudden Cardiac Death (2009) (21)
New insights into peripartum cardiomyopathy using cardiac magnetic resonance imaging. (2011) (21)
NF- k B activation is required for adaptive cardiac hypertrophy (2009) (20)
Mutations in the EGF-CFC Gene Cryptic Are an Infrequent Cause of Congenital Heart Disease (2006) (20)
Increasing Awareness and Perception of Heart Failure in Europe and Improving Care—Rationale and Design of the SHAPE Study (2004) (20)
Diazepam. A useful hypnotic drug for direct-current cardioversion. (1968) (20)
Modulation of Sympathetic Vasoconstriction by Potassium (1984) (20)
Stat1 Nuclear Translocation by Nucleolin upon Monocyte Differentiation (2009) (19)
Ischaemia-Induced Noradrenaline Release Mediates Ventricular Arrhythmias (1989) (19)
Regulation of cardiac adrenomedullin-mRNA in different stages of experimental heart failure. (1999) (19)
Percutaneous Coronary Intervention in Patients with End-Stage Renal Disease (2006) (19)
Positive cardiac troponin I and T and chest pain in a patient with iatrogenic hypothyroidism and no coronary artery disease. (2007) (19)
Angiotensin II and coronary artery disease, congestive heart failure, and sudden cardiac death (1998) (19)
Magnetic resonance planimetry of the vena contracta as a new approach to assessment of stenotic heart valves: An in vitro study (2001) (19)
Urokinase activates calcium-dependent potassium channels in U937 cells via calcium release from intracellular stores. (1999) (19)
E 2 F-1 Overexpression in Cardiomyocytes Induces Downregulation of p 21 CIP 1 and p 27 KIP 1 and Release of Active Cyclin-Dependent Kinases in the Presence of Insulin-Like Growth Factor I (1999) (18)
Neurohumoral Blockade in CHF Management (2000) (18)
Catecholamines in Myocardial Hypoxia and Ischemia (1981) (18)
Expression analysis using oligonucleotide microarrays in mice lacking bradykinin type 2 receptors. (2001) (17)
Cardiac and Renal Effects of Growth Hormone in Volume Overload–Induced Heart Failure: Role of NO (2002) (17)
Pressure dependent release of atrial natriuretic peptide (ANP) in patients with chronic cardiac diseases: does it reset? (1986) (17)
Plasma catecholamines, noradrenaline metabolism and vascular response in desoxycorticosterone acetate hypertension of rats. (1981) (17)
Visinin-like protein 1 regulates natriuretic peptide receptor B in the heart (2010) (17)
The tight junction protein ZO-2 mediates proliferation of vascular smooth muscle cells via regulation of Stat1. (2009) (17)
Forced Homodimerization by Site-Directed Mutagenesis Alters Guanylyl Cyclase Activity of Natriuretic Peptide Receptor B (2004) (16)
The role of potassium in hypertension. Discovery of potassium as a natriuretic and antihypertensive agent. (1983) (16)
Vasopressor systems during smoking in humans. (1984) (16)
Influence of low sampling rate on heart rate variability analysis based on non-linear dynamics (1995) (16)
Assessment of Late Gadolinium Enhancement in Nonischemic Cardiomyopathy: Comparison of a Fast Phase-Sensitive Inversion Recovery Sequence (PSIR) and a Conventional Segmented 2D Gradient Echo Recall (GRE) Sequence—Preliminary Findings (2007) (16)
MR coronary angiography using 3D-SSFP with and without contrast application. (2005) (16)
Ramipril and captopril in patients with heart failure: effects on hemodynamics and vasoconstrictor systems. (1987) (16)
Is there a common genetic basis for all familial cardiomyopathies? (2007) (15)
α1A-Adrenergic Receptor-Directed Autoimmunity Induces Left Ventricular Damage and Diastolic Dysfunction in Rats (2010) (14)
Reduction of right ventricular pacing in patients with sinus node dysfunction through programming a long atrioventricular delay along with the DDIR mode (2008) (14)
Salt loss as a possible mechanism eliciting an acute malignant phase in renal hypertensive rats (1975) (14)
Use of corticosteroid antibodies for the study of corticosteroid biosynthesis in vitro. (1975) (14)
Letter regarding article by Sharkey et al, "Acute and reversible cardiomyopathy provoked by stress in women from the United States". (2005) (14)
Requirements on sampling rate in Holter systems for analysis of heart rate variability. (1996) (14)
Angiotensin inhibition and atrial natriuretic peptide release after acute volume expansion in rats with aortocaval shunt. (1999) (14)
Telmisartan Effectiveness on Left ventricular MAss Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension — a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months — rationale and study design (2003) (14)
Transcription, storage and release of atrial natriuretic factor in the failing human heart. (1991) (14)
Are diuretics overused in the treatment of chronic heart failure? (2008) (13)
The Biomaterialbank of the German Competence Network of Heart Failure (CNHF) is a valuable resource for biomedical and genetic research. (2009) (13)
Assessment of the effect of external counterpulsation on myocardial adaptive arteriogenesis by invasive functional measurements--design of the arteriogenesis network trial 2. (2010) (13)
Sequence analysis of myozenin 2 in 438 European patients with familial hypertrophic cardiomyopathy. (2008) (13)
Effect of neonatal sympathectomy by 6-hydroxydopamine on volume and resistance regulation in stroke-prone spontaneously hypertensive rats. (1979) (12)
[Renovascular illness: prevalence and therapy in patients with coronary heart disease]. (2000) (12)
The G-231A polymorphism in the endothelin-A receptor gene is associated with lower aortic pressure in patients with dilated cardiomyopathy. (2007) (12)
Pseudothrombocytopenia After Abciximab (ReoPro) Treatment (1999) (12)
Is routine ultrasound guidance really necessary for closure of patent foramen ovale using the Amplatzer PFO occluder? (2009) (12)
Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators. (2012) (12)
Aldosterone and corticosterone production in renal hypertensive rats. (1975) (12)
Euro Heart Failure Survey: Unzureichende Umsetzung der aktuellen Leitlinien bei der medikamentoesen Therapie der chronischen Herzinsuffizienz [Euro Heart Failure Survey: Medical treatment not in line with current guidelines] (2005) (12)
Interactions Between the Renin‐Angiotensin System and the Parasympathetic Nervous System in Heart Failure (1994) (12)
Reference values for cardiac troponins I and T in a goal-oriented concept of health: cardiac marker values in a series of outpatients without acute coronary syndromes. (2004) (12)
Franz Volhard in historical perspective. (1993) (11)
Facilitated percutaneous coronary intervention (PCI) in patients with acute ST-elevation myocardial infarction: comparison of prehospital tirofiban versus fibrinolysis before direct PCI. (2005) (11)
The frequency of occurrence of anti-cardiac receptor autoantibodies and their correlation with clinical manifestation in patients with hypertrophic cardiomyopathy. (1999) (11)
Chymase gene locus is not associated with myocardial infarction and is not linked to heart size or blood pressure. (1998) (11)
Detection of patients with coronary artery disease using cardiac magnetic field mapping at rest. (2007) (11)
Modulation of coronary circulation and the cardiac matrix by the renin-angiotensin system. (1991) (11)
Interaction of the renin-angiotensin system and the endothelin system in cardiac hypertrophy. (1998) (11)
Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design. (2003) (11)
Atrial natriuretic factor. Its possible role in hypertension and congestive heart failure. (1989) (11)
The renin-angiotensin system in acute renal failure of rats. (1975) (11)
Angiotensin-converting enzyme inhibition, autonomic activity, and hemodynamics in patients with heart failure who perform isometric exercise. (1996) (11)
Stressechocardiography for risk stratification of asymptomatic patients with type 2 diabetes mellitus (2009) (10)
Cardiopulmonary auscultation: duo for strings--Opus 99. (1999) (10)
Randomized, double-blind, placebo-controlled trial of growth hormone in patients with dilated cardiomyopathy (1998) (10)
[Left ventricular function and activity of vasoconstrictor systems in patients with chronic heart insufficiency]. (1984) (10)
Relationships between haemodynamic parameters and concentrations of atrial natriuretic peptide in human plasma. (1986) (10)
Ventricular Remodeling after Acute Myocardial Infarction (1999) (10)
Improvement of diastolic filling in hypertensive patients treated with cilazapril. (1991) (10)
Pericardial effusion as primary manifestation of Takayasu arteritis. (2010) (9)
Effect of chronic volume overload on baroreflex control of heart rate and sympathetic nerve activity. (1997) (9)
Acute hemodynamic and renal effects of adrenomedullin in rats with aortocaval shunt. (1999) (9)
Heart Failure and Arrhythmias (1990) (9)
[New methods for the detection of high risk patients in cardiology]. (1994) (9)
Effect of chronic volume overload on baroreflex control of heart rate and sympathetic nerve activity. (1997) (9)
QT Prolongation and Syncope with Methadone, Doxepin, and a β-Blocker (2005) (9)
Intracerebroventricular angiotensin II increases arterial blood pressure in rhesus monkeys by stimulation of pituitary hormones and the sympathetic nervous system (1982) (9)
Prevalence of cardiac beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy (2005) (9)
Baroreceptor-mediated release of vasopressin in patients with chronic congestive heart failure and defective sympathetic responsiveness. (1992) (9)
Stents: Neue Studien — neue Trends (1997) (9)
Comparison of captopril with enalapril in the treatment of heart failure: Influence on hemodynamics and measures of renal function (1992) (8)
Pacemaker‐Based Analysis of Atrioventricular Conduction and Atrial Tachyarrhythmias in Patients with Primary Sinus Node Dysfunction (2009) (8)
Treatment with darusentan over 21 days improved cGMP generation in patients with chronic heart failure. (2002) (8)
Correction: Connective Tissue Growth Factor Overexpression in Cardiomyocytes Promotes Cardiac Hypertrophy and Protection against Pressure Overload (2009) (8)
Thrombin receptor and urokinase-type plasminogen activator are colocalized in vascular smooth muscle cells derived from human carotid atherosclerotic plaques (1996) (8)
Platelet inhibition: new agents, new strategies, new trials (1998) (8)
Renal function in high-output heart failure in rats: role of endogenous natriuretic peptides. (1999) (8)
Neue Methoden für die Erkennung von Hochrisikopatienten in der Kardiologie. New Methods for the Identification of High-risk Cardiac Patients (1994) (8)
The CAIRP (CAndesartan for In-stent Restenosis Prevention) Trial--a multicenter study of AT1-receptor blocker therapy in coronary stenting. (2008) (8)
Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism. (2007) (8)
Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing. (2009) (8)
QT prolongation and syncope with methadone, doxepin, and a beta-blocker. (2005) (8)
The significance of volume and cardiac output in the pathogenesis of hypertension. (1979) (8)
Clinical and angiographic outcome in patients with in-stent restenosis and repeat target lesion revascularisation in small coronary arteries (2000) (8)
Nf-kappab and AP-1 activation is associated with late lumen loss after porcine coronary angioplasty and antiproliferative beta-irradiation. (2007) (7)
Nonlinear dynamics in cardiovascular diseases (1997) (7)
[Anticoagulation with low molecular-weight heparin in patients with prosthetic heart valve replacements]. (1987) (7)
Erratum: Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy (Human Molecular Genetics (2008) vol. 17 (18) (2753-2765) 10.1093/hmg/ddn160) (2008) (7)
Tyk2 mediates effects of urokinase on human vascular smooth muscle cell growth. (2007) (7)
Atrial natriuretic factor and arginine vasopressin (1991) (7)
Cardiac Magnetic Field Map Topology Quantified by Kullback-Leibler Entropy Identifies Patients with Hypertrophic Cardiomyopathy (2007) (6)
Effect of captopril and lisinopril on circadian blood pressure rhythm and renal function in mild-to-moderate heart failure. (1992) (6)
Vasoconstriction and increased blood pressure in the development of accelerated vascular disease (2004) (6)
Severe mitral regurgitation after valve replacement as cause of pulmonary venous aneurysm. (2000) (6)
A rapid protocol for cardiac troponin T gene mutation detection in familial hypertrophic cardiomyopathy (1998) (6)
Growth hormone therapy in dilated cardiomyopathy monitored with MRI (1998) (6)
Lowering of blood pressure in sodium loaded rats by administration of digoxin antibodies (1982) (6)
[Sudden cardiac death in familial hypertrophic cardiomyopathy. Identification of high-risk patients]. (2005) (6)
Metabolic aspects of compensatory mechanisms in cardiac failure. (1984) (6)
Stress echocardiography for risk stratification of asymptomatic patients with type 2 diabetes mellitus. (2009) (6)
Corrigendum: Protein kinase CK2 links extracellular growth factor signaling with the control of p27Kip1 stability in the heart (2008) (6)
Epidemiology of heart failure (1997) (6)
MYOCARDIAL INFARCTION AND SCAR T 1 Mapping in Patients with Acute Myocardial Infarction (2003) (5)
Plasma HER2 levels are not associated with cardiac function or hypertrophy in control subjects and heart failure patients. (2010) (5)
Beta-blocker tolerability in elderly heart failure patients. (2009) (5)
[Induction of the atrial and ventricular ANF synthesis in experimental heart failure after aortocaval shunt]. (1993) (5)
[Severe anaphylaxis from rocuronium]. (2006) (5)
Mutations in MYOZ1 as well as MYOZ2 encoding the calsarcins are not associated with idiopathic and familial dilated cardiomyopathy. (2007) (5)
Plasma catecholamine levels and vascular response in deoxycorticosterone acetate hypertension of rats. (1980) (5)
EFFECTS OF CENTRALLY ADMINISTERED ANGIOTENSIN II AND ANGIOTENSIN II ANTAGONIST ON ARTERIAL BLOOD PRESSURE IN DIFFERENT STRAINS OF RATS (1977) (5)
Haemodynamic changes caused by alteration of autonomic activity in patients with heart failure. (1990) (5)
Effects of hydralazine on sympathetic nervous activity in heart failure (1982) (5)
An accelerated “frontloaded” RT-PA thrombolysis regimen achives higher TIMI III patency rates in acute myocardial infarction (1994) (5)
Does the renin-angiotensin system contribute to the vascular lesions in renal hypertensive rats? (1976) (4)
Atrial natriuretic peptide mRNA in patients with heart disease. (1990) (4)
Traumatic Ventricular Aneurysm (1997) (4)
Effects of alpha- and beta-adrenoceptor blockade on the neurally evoked overflow of endogenous noradrenaline from the rat isolated heart. (1984) (4)
Current implementation of proven therapy in heart failure (2004) (4)
Cardiac Magnetic Resonance and Cardiac Magnetic Field Mapping in a Patient with Stress‐Induced Cardiomyopathy (Tako‐Tsubo) (2006) (4)
Hemodynamic and neuroendocrine response to acute administration of the phosphodiesterase inhibitor BM 14.478 in patients with congestive heart failure (1991) (4)
Multiparametric heart rate variability analysis for high risk stratification after myocardial infarction. (1996) (4)
Interstitial pneumonitis with accumulation of intraalveolar macrophages, a facet Amiodarone therapy (2008) (4)
Corrigendum: Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy (2005) (4)
224 Myocarditis: relation between myocardial edema and myocardial mass during the acute and convalescent phase. Insights from CMR (2008) (4)
[New aspects of ACE inhibitor treatment of heart failure]. (1996) (4)
[Arrhythmogenic right ventricular cardiomyopathy]. (2018) (4)
Comparison of the first-dose effect of captopril and lisinopril in heart failure. (1992) (3)
Returning hypertrophy after surgery in a patient with hypertrophic cardiomyopathy caused by a myosin-binding protein C mutation. (2005) (3)
FLUID AND SALT INTAKE DURING THE DEVELOPMENT OF RENAL HYPERTENSION IN RATS (1980) (3)
Acute and chronic neutral endopeptidase inhibition and the natriuretic response to acute volume expansion. (1998) (3)
Regulation of the intravascular volume and of the total peripheral resistance in spontaneous hypertensive rats. (1979) (3)
[Therapy of heart failure with beta-blockers?]. (1997) (3)
[Reflex regulation of heart rate in patients with heart failure]. (1988) (3)
Amelioration of Angiotensin Ii-Induced Cardiac Injury by Hmg-Coa Reductase Inhibition (2000) (3)
selectin SER 128 ARG gene polymorphism and restenosis after successful coronary angioplasty (2002) (3)
Circulatory response to pressor agents in phosphorous depletion. (1982) (3)
Increased rate of evolution of QRS changes in patients with acute myocardial infarction. Results from the Vermut Study. (1993) (3)
What makes the renin-angiotensin system a pathogenic factor? (1978) (3)
Circadian rhythm of blood pressure in congestive heart failure and effects of ACE inhibitors. (1991) (3)
Time course of changes in cardiac magnetic field mapping after myocardial infarction in rats (2007) (3)
The background of the MERIT-HF trial (2000) (3)
Niebauer Euro heart failure survey Medical treatment not in line with current guidelines (2005) (3)
Th-P16:340 Urokinase receptor and RHOA mediate non-lipid lowering effects of rosuvastatin on vascular remodeling (2006) (3)
Images in cardiovascular medicine: pseudothrombocytopenia after abciximab (ReoPro) treatment. (1999) (2)
Severe agitation and hyperventilation after contrast media application during coronary angiography (1999) (2)
Postoperative pulmonary arteriovenous fistula resulting in recurrent cryptogenic stroke. (2007) (2)
Effect of Vasodilator Therapy on Sympathetic Activity in Patients with Impaired Left Ventricular Function (1981) (2)
Plasma concentrations of atrial natriuretic peptide during physical exercise in patients with congestive heart failure (2005) (2)
3528 POSTER Fatigue in pancreatic cancer: the potential link between exertional dyspnea, exercise limitation, skeletal musculature and neurohormonal activation (2007) (2)
[Effects of angiotensin-converting enzyme inhibitors in heart failure]. (1988) (2)
[Genetics of dilated cardiomyopathy]. (2001) (2)
Biatrial cardiac myxoma. (2000) (2)
The intron 6 G/T polymorphism of c-myb oncogene and the risk for coronary in-stent restenosis (2004) (2)
Effects of beta-adrenergic blocking agents on peripheral vascular resistance. (1978) (2)
A message in a bottle: a case report (2008) (2)
The problem of reocclusion and restenosis — Clinical aspects (1995) (2)
[Thrombolytic therapy of renal artery embolism. An expanded case report with review of the literature]. (1996) (2)
[Interaction between the renin system and parasympathetic nervous system in heart failure]. (1993) (2)
Growth hormone therapy in heart failure (1999) (2)
[Management of heart failure: ambition and reality in the early 21st Century]. (2003) (2)
Insulin-like growth factor-l and risk of breast cancer (1998) (2)
[Therapy with ACE inhibitors in chronic heart failure and limited kidney function]. (1994) (1)
sodium diet in stroke-prone spontaneously hypertensive rats Contribution of the sympathetic nervous system to the hypertensive effect of a high (2011) (1)
Indication for bromocriptine in peripartum cardiomyopathy (2009) (1)
Inhibition of the renin-angiotensin-system in brattleboro rats with hereditary hypothalamic diabetes insipidus (2005) (1)
Soluble epoxide hydrolase (Ephx2) is a susceptibility gene for heart failure in a rat model of human disease 3044 (2008) (1)
Blood Pressure-Independent ETA and AT1 Receptor Blocker Effects on the Coronaries of Rats Harboring Human Renin and Angiotensinogen Genes (2005) (1)
Irreversible shock in rats after injection of microspheres into the renal artery (1977) (1)
[24-hour blood pressure and renal function in cardiac failure during the titration phase of captopril and enalapril]. (1990) (1)
1145-123 Inadequate perception of heart failure is associated with underuse of diagnostic and therapeutic strategies in heart failure by the primary care physician: Results from SHAPE, a major European survey (2004) (1)
A left-to-left shunt. (1999) (1)
294 Hypoxia/reoxygenation induces neonatal cardiomyocyte hypertrophy: Activation of CREB downstream of PI3K and ERK pathway (2003) (1)
[Atrial fibrillation in patients with heart failure. Pathophysiological concepts and therapeutic options]. (2008) (1)
Dosing of ACE inhibitors in postinfarct protection (1993) (1)
[Comparison of captopril with enalapril in the therapy of heart failure: effect on hemodynamics and kidney function]. (1988) (1)
Long-term survival of routine implantable cardioverter/defibrillator recipients appears to be significantly impaired with concomitant diuretics and improved with aldosterone antagonists. (2011) (1)
Plasma levels of opioid peptides and naloxone effects in canine hemorrhagic shock (1982) (1)
[Enalapril versus captopril in heart failure--effect on blood pressure and kidney function]. (1991) (1)
Neurohumoral blockade in CHF management (2000) (1)
Sympathischer Gefäßtonus bei β-Blockade (1977) (1)
How does heparin enhance thrombolysis (1994) (1)
Effects of low-molecular weight and high-molecular weight heparin on the intrinsic and extrinsic endogenous fibrinolytic system (1994) (1)
Prävention der Reokklusion (1997) (1)
Variations in therapy for heart failure in Europe: from perceptions to practice. A study of over 1300 physicians and > 11,000 patients (2001) (1)
Vascular Smooth Muscle Cells Induced Apoptosis of − Requirement for Protein Kinase C in Reactive Oxygen Species (1999) (1)
[Does the measurement of plasma ANP have a diagnostic or prognostic value in patients with organic heart disease?]. (1988) (1)
High resolution ECG versus heart variability - new results in risk stratification (1994) (1)
Diagnosis of heart failure in Europe: a survey of perceptions and practice from over 1300 physicians and over 11,000 of their patients (2001) (1)
[Acute treatment of stable hemodynamically tolerable ventricular tachycardia]. (2005) (1)
[Sympathetic vascular tonus in beta blockade]. (1977) (1)
Different antagonist potency of saralasin in acute and chronic angiotensin-dependent hypertension. (1983) (1)
[Therapy of dilated cardiomyopathy with recombinant human growth hormone]. (1997) (1)
Acute alcohol-induced myocardial inflammation as visualized by cardiac magnetic resonance (2008) (1)
1 Symbolic Dynamics-a Powerful Tool in Non-Invasive Biomedical Signal Processing (2000) (1)
[Clinical findings with inhibitors of the renin-angiotensin system]. (1993) (1)
Fragmentation Pattern of Fibrinogen During Thrombolysis in Acute Myocardial Infarction with Fibrin-Specific Plasminogen Activators - Detection of High-Molecular Weight Fibrinogen Degradation Products (1994) (1)
Influence of Angiotensin on ANP Release and Renal Response to Volume Expansion in Moderate Heart Failure (1998) (1)
Insulin-like growth factor-I and risk of breast cancer. (1998) (1)
[Cardiac manifestations of muscular dystrophies]. (2005) (1)
Magnetocardiography — A New Approach for Early Detection of Arrhythmogenic Right Ventricular Dysplasia (2000) (1)
[Role of the sympathetic nervous system in heart failure]. (1991) (1)
[Thrombolysis in acute myocardial infarct. An improved long-term prognosis following balloon dilatation]. (2008) (1)
Morphogenesis of hypertensive vascular lesions. (1982) (1)
[Changes in kidney function during treatment of heart failure patients with ACE inhibitors]. (1991) (0)
Spreading of the new treatments in heart failure. Presentation of an initiative: Improvement of heart failure (2000) (0)
Cardiac output and volume in hypertension (1979) (0)
150 Angiotensin I converting enzyme 2 and dilated cardiomyopathy ‐ association of the 8790G>A polymorphism with left ventricular ejection fraction (2003) (0)
High resolution ECG and heart rate variability (1996) (0)
397 Heart rate variability correlates with symptoms of heart failure in patients with diastolic dysfunction (2006) (0)
Abstract 856: Renal Tissue Perfusion Increases After Interventional Therapy In Patients With Unilateral Renal Artery Stenosis (2008) (0)
Increased mortality associated with growth hormone treatment in critically ill adults. (2000) (0)
Hungarian results of the IMPROVEMENT HF European survey on the everyday diagnostics and treatment of heart failure: Comparison of European and Hungarian data (2003) (0)
Coronary Artery-To-Left Ventricular Fistula - Reply (1999) (0)
Inhibition of the Renin-Angiotensin-System (RAS) in Rats with Hereditary Hypothalamic Diabetes Insipidus (DI) (1978) (0)
458 Poor treatment of patients with heart failure: lack of knowledge of current guidelines by cardiologists or too few patients treated by cardiologists? Results of SHAPE (2005) (0)
[Variable action of central and peripheral angiotensin II blockade in genetic hypertension in rats]. (1977) (0)
USE OF CORTICOSTEROID ANTIBODIES FOR THE STUDY OF CORTICOSTEROID BIOSYNTHESIS IN VITRO (1976) (0)
Reperfusion hemorrhage is a marker for the severity of tissue injury in patients with acute ST-elevation myocardial infarction (2010) (0)
Running Title: GP IIb/IIIa inhibitor and cardiac events (2017) (0)
, Roland Willenbrock and of Natriuretic Peptide Receptor B Forced Homodimerization by Site-Directed Mutagenesis Alters Guanylyl Cyclase Activity (2004) (0)
Abstract 1960: Conservative vs. Interventional Treatment of Angio-Seal-Induced Femoral Artery Stenoses Complicating Coronary Angiography (2006) (0)
[Effect of propranolol and bunotrolol on the sympathico-adrenal activity]. (1978) (0)
[The role of peripherally acting drugs in the treatment of chronic heart failure]. (1991) (0)
The safety of clinical cardiovascular magnetic resonance imaging: a single-center experience in more than 3,000 cases (2002) (0)
ASERIESOFHOSPITALIZED PATIENTSWITHELEVATED DIGOXINLEVELS (1999) (0)
[Therapy of heart failure with angiotensin converting enzyme inhibitors. Effects on renal function]. (1989) (0)
Evaluation of the Severity of Heart Failure: Role of Compensatory Mechanisms (1990) (0)
[The hypotension risk during the therapy of heart failure with ACE inhibitors]. (1993) (0)
[Balloon dilatation in unstable angina pectoris and acute myocardial infarct]. (1987) (0)
The Role of Arginine-Vasopressin in Blood Pressure Control (1983) (0)
[Risk predictors and secondary prevention after PTCA and bypass operations]. (1995) (0)
[Stents: new studies--new trends]. (1997) (0)
105 First evaluation of a novel questionnaire for physical wellbeing in patients with heart failure (2008) (0)
Poster session 3: Miscellaneous (2009) (0)
Abstract 5808: Assessment of Aortic Bioprostheses is Feasible Applying Cardiovascular Magnetic Resonance - In Vivo and In Vitro Studies (2008) (0)
364 Risk stratification of patients with chronic heart failure based on metabolic functional and haemodynamic parameters (2008) (0)
Featured Posters: An overview of cardiac electrophysiology and pacing (2009) (0)
Review Article A Systematic Meta-Analysis of the Efficacy and Heterogeneity of Disease Management Programs in Congestive Heart Failure (2006) (0)
1005-42 Recanalization of long superficial femoral artery occlusions by a transpopliteal approach: Acute and 12-month results (2004) (0)
Recruiting and Baseline of the HIV-HEART Study: A Prospective, Multicenter Trial to Analyze Cardiac Diseases in HIV-Infected Patients (2010) (0)
A functional cross-talk of KLF15 to the Wnt signalling pathway and its role in adult cardiac precursor cell regulation (2010) (0)
Verapamil treatmentafter coronaryangioplasty in patients athighrisk ofrecurrentstenosis (1994) (0)
P-150 Cardiac resynchronization therapy: Correlation between initial QRS width and improved heart rate variability during follow-up (2003) (0)
533 Euro Heart Survey. Heart failure: medical treatment not in line with current guidelines (2004) (0)
Thrombolytic therapy is a promising therapeutic option for patients with renal arterial embolism (1996) (0)
Analysis of heart rate variability versus high resolution ECG (1995) (0)
Antiarrhythmic effects of ACE-inhibitors during myocardial ischaemia? (1990) (0)
Abstract 2829: Increased Soluble Vitronectin Receptor Levels Predict Risk in Patients Undergoing Coronary Stenting (2007) (0)
B: Effect of sympathetic nerve stimulation Release of endogenous catecholamines in the ischemic myocardium of the rat. Part (2011) (0)
1024 A novel CMR-based myocardial salvage index predicts left ventricular remodeling after acute myocardial infarction: insights from T2-weighted and late gadolinium enhancement imaging (2008) (0)
Delayed contrast enhancement on magnetic resonance images is associated with conduction slowing in patients with hypertrophic cardiomyopathy (2005) (0)
Abstracts: Genetics in arrhythmiasThe R14Del mutation in phospholamban causes familial dilated cardiomyopathy with attenuated electrocardiographic R amplitudesGenetic variants in NPPA encoding the atrial natriuretic peptide precursor are associated with atrial fibrillationTriple mutation of SCN5A as (2009) (0)
Humoral adaptation mechanisms and clinical outcome during vasodilator therapy. (1988) (0)
[OCTAVE and OPERA: discordance in hypertension therapy?]. (2004) (0)
Abstract 15154: Interaction of Krueppel-Like Factor (klf) 15 and Wnt-Signaling Pathway and its Role in Adult Cardiac Precursor Cell Regulation (2011) (0)
[Possible mechanisms of action of potassium in arterial hypertension]. (1984) (0)
Risk of Myocardial Infarction Following Coronary Stent Implantation without Adequate Clopidogrel Treatment (2006) (0)
Klinische Erfahrungen mit Hemmern des Renin-Angiotensin-Systems [Clinical findings with inhibitors of the renin-angiotensin system] (1993) (0)
Characterization of cardiovascular diseases by measures of non-linear dynamics (1996) (0)
Nonlinear dynamics in cardiovasscular diseases (1997) (0)
Effect of dietary sodium and potassium content on sympathetic activity in spSHR (1981) (0)
Contrast enhanced cardiovascular magnetic resonance imaging prior to prophylactic implantation of a cardioverter/defibrillator identifies patients with increased risk for ventricular arrhythmias (2009) (0)
PCV66 POOLED EFFICACY OF DISEASE MANAGEMENT PROGRAMS IN PATIENTS WITH CONGESTIVE HEART FAILURE—A SYSTEMATIC REVIEW (2004) (0)
[What role does the renin-angiotensin system have in the pathogenesis of hypertension?]. (1977) (0)
Abstract 1317: Progression Of Carotid Intima-media Thickness Is Associated With Platelet-leucocyte Activation In Patients With Diabetes mellitus Type 2. (2007) (0)
[Cardiomyopathy and immune competence in heart insufficiency]. (2005) (0)
The kidney after removal of one renal artery stenosis in the rat. (1976) (0)
47 Coronary venous anatomy and transvenous lead placement at the left ventricular lateral wall (2005) (0)
Non-invasive measurement of the myocardial functional capacity during isometric exercise (1992) (0)
Abstract 215: Arc Transcriptional Regulation And Degradation Is A Critical Cardiomyocyte Survival Switch In Doxorubicin-cardiotoxicity (2008) (0)
Renovascular hypertension. (1984) (0)
Indication for bromocriptine in peripartum cardiomyopathy: reply (2009) (0)
A: Locally mediated release Release of endogenous catecholamines in the ischemic myocardium of the rat. Part (2011) (0)
Abstracts: Cardiac resynchronisation therapy: results and mechanisms (2009) (0)
Renal and hemodynamic effects of growth hormone treatment in experimental heart failure (1998) (0)
[5-year survival rate in acute transmural heart infarct following thrombolysis and immediate coronary angioplasty]. (1988) (0)
1008 Contrast enhanced cardiovascular magnetic resonance imaging prior to prophylactic implantation of a cardioverter/defibrillator identifies patients with increased risk for ventricular arrhythmias (2008) (0)
303. Adrenocortical activity in different types of renal hypertension (1974) (0)
[Modification of genetic hypertension in rats]. (1977) (0)
Effects of Hydralazine and Isosorbide Dinitrate on Vasoconstrictor Mechanisms in Patients with Heart Failure (1983) (0)
PCV47 DECISION ANALYSIS ON EFFECTIVENESS AND COST-EFFECTIVENESS OF DISEASE MANAGEMENT PROGRAMS FOR THE TREATMENT OF HEART FAILURE (2004) (0)
678 The incidence of ventricular pacing in patients with sinus node dysfunction and preserved AV conduction can be reduced using long AV delays and the DDIR mode (2005) (0)
1109 Quantification of the orifice area of bioprostheses in aortic position by cardiovascular magnetic resonance (2008) (0)
Subject Index Vol. 28, 2005 (2006) (0)
[ACE inhibition: mechanisms of cardioprotection in chronic heart failure]. (1991) (0)
Combination of Single-Chain Urokinase-Type Plasminogen Activator and Recombinant Tissue-Type Plasminogen Activator in Acute Myocardial Infarction (2005) (0)
Images in clinical medicine. Traumatic ventricular aneurysm. (1997) (0)
P5-16: Electrical remodeling in hypertension induced endorgan damage can be detected noninvasively by cardiac magnetic field mapping (2006) (0)
CRT16: CARDIAC RESYNCHRONIZATION THERAPY: A POSSIBLE OPTION FOR REFRACTORY END-STAGE HEART FAILURE (2005) (0)
The cardiac renin-angiotensin system and human coronary physiology and pathology (1994) (0)
Abstract 1467: Vascular Endothelial Cell-Specific Suppression of NF-{kappa}B Activity Attenuates Hypertension-Induced Cardiovascular End Organ Damage (2006) (0)
[Vascular changes in genetic hypertension in rats]. (1977) (0)
Cycling and sports are associated with lower 10-year cardiovascular disease (0)
AS-201: Connective Tissue Growth Factor Promoter Polymorphism in Patients with Acute Coronary Syndromes (2010) (0)
[Increased sensitivity of vascular muscles in renal and corticosterone hypertension]. (1977) (0)
2036 Acute alcohol-induced myocardial inflammation as visualized by cardiac magnetic resonance (2008) (0)
Endocarditis and extrinsic coronary compression. (2002) (0)
Ventricular tachycardia as the first manifestation of cardiac sarcoidosis (2009) (0)
[Percutaneous transfemoral valvuloplasty in patients with calcified aortic stenosis and significantly increased surgical risk: clinical course and value of Doppler sonography in assessment of therapeutic success]. (1988) (0)
Personal and Historical Perspectives Franz Volhard in Historical Perspective (1993) (0)
Nuclear Translocation by Nucleolin upon Monocyte Differentiation (2009) (0)
[Infectious endocarditis]. (2003) (0)
Kardiale Manifestationen bei Muskeldystrophien [Cardiac manifestations of muscular dystrophies] (2005) (0)
407 Candesartan is cost‐effective in heart failure ‐ an economic analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme (2005) (0)
[Painless aortic dissection: the problem of early diagnosis. A case report]. (1988) (0)
2038 CMR detects transient and permanent myocardial injury in Churg-Strauss syndrome (2008) (0)
Continuous 3-dimensional vectorcardiography, a valuable tool for online ischemia monitoring (1995) (0)
Taming of the shrew. (2003) (0)
139 Myocardial stabilization of beta‐catenin abrogates adaptive cardiac hypertrophy in vivo (2007) (0)
[AT 1-blocker can be given in addition to ACE inhibitor and beta blocker. "Triple therapy decidedly well tolerated even in severe heart failure"]. (2004) (0)
recurrent stenosis . angioplasty in patients at high risk of Verapamil treatment after coronary (2003) (0)
Magnetophysiologic phenotype of patients with arrhythmogenic right ventricular cardiomyopathy with ventricular tachyarrhythmias (2007) (0)
381 Inhibition of beta‐catenin suppresses left ventricular remodelling after infarct (2007) (0)
A38-2 Possible hemodynamic impairment by conventional right ventricular pacing: How many patients are affected? (2003) (0)
Poster Session 2: Primary prevention (2009) (0)
318 Specialist awareness of and adherence to clinical guidelines for management of chronic heart failure (CHF) (2007) (0)
Biomagnetic Evidence for Extreme Anisotropy — A Mechanism Limiting Conduction Capability in Accessory Pathways (2000) (0)
[Drug therapy for prognostic improvement after acute myocardial infarct]. (1999) (0)
[Reparative effects of ACE inhibitors on the heart]. (1992) (0)
249 Heart‐specific inhibition of transcription factor NFkappaB partially abrogates angiotensinII‐induced hypertrophy in transgenic mice (2003) (0)
[Current status of therapy of chronic heart failure]. (2000) (0)
670 Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial (2008) (0)
387 Relation of myocardial repolarisation and conduction to diastolic function and left ventricular hypertrophy in hypertensive patients (2006) (0)
Contents Vol. 28, 2005 (2006) (0)
Abstract 1418: Modulation Of Beta-catenin Enhances Endogenous Myocardial Repair After Experimental Infarct (2008) (0)
Baroreflex sensitivity as a prognostic factor in patients with heart failure (1992) (0)
Catecholamine Release in Myocardial Ischemia and Its Clinical Implications (1986) (0)
Cannula for vascular puncture (1994) (0)
Volhard, Franz in historical perspective (1993) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Rainer Prof Dr Dietz?

Rainer Prof Dr Dietz is affiliated with the following schools:

Rainer Prof Dr Dietz's Academic­Influence.com Rankings

Why Is Rainer Prof Dr Dietz Influential?

Rainer Prof Dr Dietz's Published Works

Published Works

What Schools Are Affiliated With Rainer Prof Dr Dietz?

Rainer Prof Dr Dietz's AcademicInfluence.com Rankings